Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Catalent Inc. (NYSE: CTLT).

Full DD Report for CTLT

You must become a subscriber to view this report.


Recent News from (NYSE: CTLT)

Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine
NEW HAVEN, Conn. , Dec. 3, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced positive topline results from a randomized, controlled Phase 3 clinical trial (BHV3000-303 or Study 303) evaluating the efficacy and safety of its Zydis ® oral...
Source: PR Newswire
Date: December, 03 2018 03:00
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2018 Update
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 11/14/2018. Please visit our Tracking Ole Andreas Halvorsen...
Source: SeekingAlpha
Date: November, 26 2018 10:05
Catalent 2019 Q1 - Results - Earnings Call Slides
The following slide deck was published by Catalent in conjunction with their 2019 Q1 earnings Read more ...
Source: SeekingAlpha
Date: November, 06 2018 15:23
Catalent (CTLT) Q1 2019 Results - Earnings Call Transcript
Catalent, Inc. (CTLT) Q1 2019 Earnings Call November 06, 2018 8:15 am ET Executives Thomas Castellano - Catalent, Inc. John R. Chiminski - Catalent, Inc. Wetteny Joseph - Catalent, Inc. Analysts Julia Qin - JPMorgan Securities LLC Juan E. Avendano - Bank of America Merril...
Source: SeekingAlpha
Date: November, 06 2018 14:24
Catalent FQ1 miss pressures shares, down 14%
Catalent ( CTLT -14.1% ) is down on below-average volume following the release of fiscal Q1 results that were shy of consensus. Highlights: More news on: Catalent, Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more ...
Source: SeekingAlpha
Date: November, 06 2018 10:57
Catalent EPS in-line, misses on revenue
Catalent (NYSE: CTLT ): Q1 Non-GAAP EPS of $0.28 in-line; GAAP EPS of -$0.10 misses by $0.20 . More news on: Catalent, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: November, 06 2018 07:32
Catalent, Inc. Reports First Quarter Fiscal 2019 Results
Q1'19 revenue of $551.8 million increased 1% as-reported, or 3% in constant currency, from the prior-year period. Closed the acquisition of Juniper Pharmaceuticals, a European early development Center of Excellence with dose form development and clinical manufacturing capabilitie...
Source: Business Wire
Date: November, 06 2018 07:30
Notable earnings before Tuesday's open
AAC , ABC , ADM , AES , AFI , ANIP , APD , AVNS , BCC , BCPC , BDX , BHC , BIOS , BLD , BR , CORE , CTLT , CVS , ELAN , EMES , EMR , ETM , EXPD , FI , FRTA , FSS , GCP , GLDD , GLT , GOGO , GTN , GTX , HAE , HPT , HSIC , IONS , IRWD , JELD , JLL , KEYW...
Source: SeekingAlpha
Date: November, 05 2018 17:30
Catalent, Inc. to Present at Three Upcoming Investor Conferences
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Wetteny Joseph, Senior Vice President & Chief Financial Officer, and Thomas Castellano, Vice Presid...
Source: Business Wire
Date: October, 31 2018 16:15
Report: Exploring Fundamental Drivers Behind The Home Depot, uniQure N.V, Catalent, Apple, BioTime, and PDL BioPharma - New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Home Depot, Inc. (NYSE:HD), uniQure N.V. (NASDAQ:QURE), Catalent, Inc...
Source: GlobeNewswire
Date: October, 23 2018 07:45

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1442.1342.7643.02542.13726,416
2017-11-2739.4639.3639.6739.071,187,454
2017-11-2439.4739.4939.8739.24366,105
2017-11-2238.8638.9239.2938.83545,268
2017-11-2138.9438.9139.1638.50798,970

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-174,13112,11734.0926Cover
2018-12-1441,88845,96091.1401Short
2018-12-138294,69217.6684Cover
2018-12-121,7885,51532.4207Cover
2018-12-111,80656,8913.1745Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CTLT.


About Catalent Inc. (NYSE: CTLT)

Logo for Catalent Inc. (NYSE: CTLT)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $5,266,752,907 - 05/17/2018
  • Issue and Outstanding: 133,369,281 - 04/27/2018

 


Recent Filings from (NYSE: CTLT)

Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: September, 05 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: September, 04 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: September, 04 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: September, 04 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: September, 04 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: September, 04 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: September, 04 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: September, 04 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: September, 04 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: September, 04 2018

 

 


Daily Technical Chart for (NYSE: CTLT)

Daily Technical Chart for (NYSE: CTLT)


Stay tuned for daily updates and more on (NYSE: CTLT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: CTLT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CTLT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CTLT and does not buy, sell, or trade any shares of CTLT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/